| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Payments of offering costs | 0 | 0 |
| Net cash provided by financing activities | 10 | 10 |
| Net increase in cash and cash equivalents | 18,219 | -4,458 |
| Cash and cash equivalents at beginning of period | 13,903 | - |
| Cash and cash equivalents at end of period | 32,122 | - |
Rallybio Corp (RLYB)
Rallybio Corp (RLYB)